Jefferies Financial Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,200
Closed -$1.16M 1433
2025
Q2
$1.16M Hold
20,200
0.01% 684
2025
Q1
$2.19M Sell
20,200
-3,800
-16% -$331K 0.02% 551
2024
Q4
$1.14M Hold
24,000
0.01% 838
2024
Q3
$2.36M Buy
24,000
+9,440
+65% +$1.22M 0.02% 544
2024
Q2
$2.38M Buy
14,560
+1,080
+8% +$154K 0.03% 494
2024
Q1
$2.06M Buy
13,480
+7,600
+129% +$1.26M 0.02% 588
2023
Q4
$1.84M Buy
+5,880
New +$2.13M 0.01% 742
2023
Q3
Sell
-200
Closed -$86.7K 1591
2023
Q2
$86.7K Sell
200
-1,000
-83% -$562K ﹤0.01% 1515
2023
Q1
$713K Buy
1,200
+200
+20% +$112K 0.01% 996
2022
Q4
$404K Buy
+1,000
New +$469K ﹤0.01% 1127

Other funds holding AGL

Jefferies Financial Group's AGL Position: Q3 2025 in Review

Jefferies Financial Group sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 19,073 shares — an estimated $1.1M sold.

Jefferies Financial Group first reported a position in AGL in Q4 2022 and held it in 10 quarters. The position peaked at $1.54M in Q1 2024. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Jefferies Financial Group reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 19,073 Agilon Health shares in Q3 2025, an estimated $1.1M.
  • Jefferies Financial Group first reported a position in Agilon Health in Q4 2022 and held it in 10 quarters.
  • Jefferies Financial Group's Agilon Health position peaked at $1.54M in Q1 2024.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Jefferies Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.